semaglutide and pancreatitis Study: Weight-loss drugs may reduce the risk of acute recurrence Reconciling GLP-1s and Pancreatitis

T.DiehlT

*Correspondence: Franco Arturi, [email protected] These authors have contributed equally to this work This article was submitted to Obesity, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Additionally, medium-chain acylcarnitines have been shown to downregulate mitochondrial complex V in type II diabetes, reducing mitochondrial oxidative capacity (Batchuluun et al., 2018)

Have established cardiovascular disease and may benefit from reduced risk of heart attack or stroke

Trulicity (dulaglutide) product information

Weight loss medications shouldnt be seen as a standalone solution